PRMT5 promotes ovarian cancer growth and Taxol response through enhancing glycolysis pathway, which mediated by regulating the symmetric dimethylation of arginine (SDMA) modification of ENO1. This evidence concerns the gene ENO1 and ovarian carcinoma.